Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T92640 | Target Info | |||
Target Name | Lysophosphatidic acid receptor 1 (LPAR1) | ||||
Synonyms | Lysophosphatidic acid receptor Edg-2; LPA1; LPA-1; LPA receptor 1; EDG2; EDG 2 receptor | ||||
Target Type | Clinical trial Target | ||||
Gene Name | LPAR1 | ||||
Biochemical Class | GPCR rhodopsin | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | [(2~{R})-2-[5-(2-hexylphenyl)pentanoylamino]-3-oxidanyl-propyl] dihydrogen phosphate | Ligand Info | |||
Canonical SMILES | CCCCCCC1=CC=CC=C1CCCCC(=O)NC(CO)COP(=O)(O)O | ||||
InChI | 1S/C20H34NO6P/c1-2-3-4-5-10-17-11-6-7-12-18(17)13-8-9-14-20(23)21-19(15-22)16-27-28(24,25)26/h6-7,11-12,19,22H,2-5,8-10,13-16H2,1H3,(H,21,23)(H2,24,25,26)/t19-/m1/s1 | ||||
InChIKey | LYWONSBDWRVEKO-LJQANCHMSA-N | ||||
PubChem Compound ID | 141702624 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 7YU3 Human Lysophosphatidic Acid Receptor 1-Gi complex bound to ONO-0740556 | ||||||
Method | Electron microscopy | Resolution | 3.50 Å | Mutation | No | [1] |
PDB Sequence |
QCFYNESIAF
32 FYNRSGKHLA42 TEWNTVSKLV52 MGLGITVCIF62 IMLANLLVMV72 AIYVNRRFHF 82 PIYYLMANLA92 AADFFAGLAY102 FYLMFNTGPN112 TRRLTVSTWL122 LRQGLIDTSL 132 TASVANLLAI142 AIERHITVFR152 MQLHTRMSNR162 RVVVVIVVIW172 TMAIVMGAIP 182 SVGWNCICDI192 ENCSNMAPLY202 SDSYLVFWAI212 FNLVTFVVMV222 VLYAHIFGYV 232 RQRTMRMDTM253 MSLLKTVVIV263 LGAFIICWTP273 GLVLLLLDVC283 CPQCDVLAYE 293 KFFLLLAEFN303 SAMNPIIYSY313 RDKEMSATFR323
|
|||||
|
TYR34
3.171
LYS39
2.642
LEU105
3.617
ASN108
4.207
THR109
3.366
GLY110
4.196
THR113
3.967
ARG124
2.503
GLN125
3.258
ILE128
4.876
ASP129
3.038
LEU132
4.789
MET198
4.696
ALA199
4.033
|
|||||
PDB ID: 7YU4 Human Lysophosphatidic Acid Receptor 1-Gi complex bound to ONO-0740556, focused on receptor | ||||||
Method | Electron microscopy | Resolution | 3.70 Å | Mutation | No | [1] |
PDB Sequence |
QCFYNESIAF
32 FYNRSGKHLA42 TEWNTVSKLV52 MGLGITVCIF62 IMLANLLVMV72 AIYVNRRFHP 83 IYYLMANLAA93 ADFFAGLAYF103 YLMFNTGPNT113 RRLTVSTWLL123 RQGLIDTSLT 133 ASVANLLAIA143 IERHITVSNR162 RVVVVIVVIW172 TMAIVMGAIP182 SVGWNCICDI 192 ENCSNMAPLY202 SDSYLVFWAI212 FNLVTFVVMV222 VLYAHIFGLL257 KTVVIVLGAF 267 IICWTPGLVL277 LLLDVCCPQC287 DVLAYEKFFL297 LLAEFNSAMN307 PIIYSYRDKE 317 MSATFR
|
|||||
|
TYR34
3.223
LYS39
2.573
LEU105
3.850
ASN108
4.361
THR109
3.307
GLY110
4.379
THR113
3.865
TRP121
4.970
ARG124
2.431
GLN125
3.416
ASP129
2.813
LEU132
4.775
MET198
4.637
ALA199
4.689
|
|||||
PDB ID: 7YU5 Human Lysophosphatidic Acid Receptor 1-Gi complex bound to ONO-0740556, state1 | ||||||
Method | Electron microscopy | Resolution | 3.70 Å | Mutation | No | [1] |
PDB Sequence |
QCFYNESIAF
32 FYNRSGKHLA42 TEWNTVSKLV52 MGLGITVCIF62 IMLANLLVMV72 AIYVNRRFHF 82 PIYYLMANLA92 AADFFAGLAY102 FYLMFNTGPN112 TRRLTVSTWL122 LRQGLIDTSL 132 TASVANLLAI142 AIERHITVFR152 MQLHTRMSNR162 RVVVVIVVIW172 TMAIVMGAIP 182 SVGWNCICDI192 ENCSNMAPLY202 SDSYLVFWAI212 FNLVTFVVMV222 VLYAHIFGYV 232 RQRTMRMDTM253 MSLLKTVVIV263 LGAFIICWTP273 GLVLLLLDVC283 CPQCDVLAYE 293 KFFLLLAEFN303 SAMNPIIYSY313 RDKEMSATFR323
|
|||||
|
TYR34
3.275
LYS39
2.718
LEU105
3.575
ASN108
4.196
THR109
3.364
GLY110
4.200
THR113
3.935
ARG124
2.534
GLN125
3.284
ILE128
4.778
ASP129
3.005
LEU132
4.739
MET198
4.625
|
|||||
PDB ID: 7YU6 Human Lysophosphatidic Acid Receptor 1-Gi complex bound to ONO-0740556, state2 | ||||||
Method | Electron microscopy | Resolution | 3.90 Å | Mutation | No | [1] |
PDB Sequence |
QCFYNESIAF
32 FYNRSGKHLA42 TEWNTVSKLV52 MGLGITVCIF62 IMLANLLVMV72 AIYVNRRFHF 82 PIYYLMANLA92 AADFFAGLAY102 FYLMFNTGPN112 TRRLTVSTWL122 LRQGLIDTSL 132 TASVANLLAI142 AIERHITVFR152 MQLHTRMSNR162 RVVVVIVVIW172 TMAIVMGAIP 182 SVGWNCICDI192 ENCSNMAPLY202 SDSYLVFWAI212 FNLVTFVVMV222 VLYAHIFGYV 232 RQRTMRMDTM253 MSLLKTVVIV263 LGAFIICWTP273 GLVLLLLDVC283 CPQCDVLAYE 293 KFFLLLAEFN303 SAMNPIIYSY313 RDKEMSATFR323
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .K6L or .K6L2 or .K6L3 or :3K6L;style chemicals stick;color identity;select .R:34 or .R:39 or .R:105 or .R:108 or .R:109 or .R:110 or .R:113 or .R:124 or .R:125 or .R:128 or .R:129 or .R:132 or .R:198 or .R:199 or .R:202 or .R:206 or .R:207 or .R:210 or .R:271 or .R:274 or .R:277 or .R:278 or .R:293 or .R:294 or .R:296 or .R:297 or .R:300; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
TYR34
3.870
LYS39
2.701
LEU105
3.546
ASN108
4.200
THR109
3.359
GLY110
4.184
THR113
3.964
ARG124
2.547
GLN125
3.244
ILE128
4.768
ASP129
3.034
LEU132
4.610
MET198
4.662
ALA199
4.062
|
|||||
PDB ID: 7YU7 Human Lysophosphatidic Acid Receptor 1-Gi complex bound to ONO-0740556, state3 | ||||||
Method | Electron microscopy | Resolution | 4.50 Å | Mutation | No | [1] |
PDB Sequence |
QCFYNESIAF
32 FYNRSGKHLA42 TEWNTVSKLV52 MGLGITVCIF62 IMLANLLVMV72 AIYVNRRFHF 82 PIYYLMANLA92 AADFFAGLAY102 FYLMFNTGPN112 TRRLTVSTWL122 LRQGLIDTSL 132 TASVANLLAI142 AIERHITVFR152 MQLHTRMSNR162 RVVVVIVVIW172 TMAIVMGAIP 182 SVGWNCICDI192 ENCSNMAPLY202 SDSYLVFWAI212 FNLVTFVVMV222 VLYAHIFGYV 232 RQRTMRMDTM253 MSLLKTVVIV263 LGAFIICWTP273 GLVLLLLDVC283 CPQCDVLAYE 293 KFFLLLAEFN303 SAMNPIIYSY313 RDKEMSATFR323
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .K6L or .K6L2 or .K6L3 or :3K6L;style chemicals stick;color identity;select .R:34 or .R:39 or .R:105 or .R:108 or .R:109 or .R:110 or .R:113 or .R:124 or .R:125 or .R:128 or .R:129 or .R:132 or .R:198 or .R:199 or .R:202 or .R:206 or .R:207 or .R:210 or .R:271 or .R:274 or .R:277 or .R:278 or .R:293 or .R:294 or .R:296 or .R:297 or .R:300; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
TYR34
3.255
LYS39
2.690
LEU105
3.632
ASN108
4.273
THR109
3.377
GLY110
4.210
THR113
4.008
ARG124
2.551
GLN125
3.289
ILE128
4.979
ASP129
3.033
LEU132
4.857
MET198
4.648
ALA199
4.074
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Structure of the active G(i)-coupled human lysophosphatidic acid receptor 1 complexed with a potent agonist. Nat Commun. 2022 Sep 15;13(1):5417. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.